Combining drug addiction treatment and perinatal HIV prevention leads to good outcomes in Kenya
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy
Protease inhibitor drug suppresses HIV in semen more slowly than drugs from other classes
Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study
Fear of stigma is prompting young South Africans to seek early HIV treatment
Early ART highly acceptable and achieves excellent rates of viral suppression among young South African women
EASL releases updated hepatitis B guidelines at International Liver Congress
A quarter of people with second-line ART treatment failure in Kenya have exhausted current treatment options
Switching from Atripla to generic-containing regimens can produce large cost savings
